CD69 and neoplasm: An upregulation of GZMB expression in tumor-infiltrating CD8+ T cells was detected in tumors treated with Z36-MP5, as well as the activation markers CD69, IFN-γ, CD25 and CD107, whose expression was augmented by combinatorial treatment with anti-PD-1 (Fig. 6f and Supplementary Fig. 9b).